{"id":"https://openalex.org/W2920558304","doi":"https://doi.org/10.3389/fcvm.2019.00016","title":"Targeting Residual Inflammatory Risk: A Shifting Paradigm for Atherosclerotic Disease","display_name":"Targeting Residual Inflammatory Risk: A Shifting Paradigm for Atherosclerotic Disease","alternate_titles":[],"publication_year":2019,"publication_date":"2019-02-27","ids":{"openalex":"https://openalex.org/W2920558304","doi":"https://doi.org/10.3389/fcvm.2019.00016","mag":"2920558304","pmid":"https://pubmed.ncbi.nlm.nih.gov/30873416","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6403155"},"language":"en","primary_location":{"id":"doi:10.3389/fcvm.2019.00016","doi":"https://doi.org/10.3389/fcvm.2019.00016","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fcvm.2019.00016","pdf_url":"https://www.frontiersin.org/articles/10.3389/fcvm.2019.00016/pdf","source":{"id":"https://openalex.org/S2595413687","display_name":"Frontiers in Cardiovascular Medicine","issn_l":"2297-055X","issn":["2297-055X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1","oarl","poland-40","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Cardiovascular Medicine","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2920558304"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fcvm.2019.00016/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002226085","display_name":"Aaron W. Aday","orcid":"https://orcid.org/0000-0001-6243-3432","observed_orcids":["https://orcid.org/0000-0001-6243-3432"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Aaron W. Aday","raw_affiliation_strings":["Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt Translational and Clinical Cardiovascular Research Center, Vanderbilt University Medical Center, Nashville, TN, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt Translational and Clinical Cardiovascular Research Center, Vanderbilt University Medical Center, Nashville, TN, United States","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5091595592","display_name":"Paul M. Ridker","orcid":"https://orcid.org/0000-0003-1249-4522","observed_orcids":["https://orcid.org/0000-0003-1249-4522"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul M. Ridker","raw_affiliation_strings":["Divisions of Preventive Medicine and Cardiovascular Medicine, Department of Medicine, Center for Cardiovascular Disease Prevention, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Divisions of Preventive Medicine and Cardiovascular Medicine, Department of Medicine, Center for Cardiovascular Disease Prevention, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5002226085"],"corresponding_institution_ids":["https://openalex.org/I901861585"],"apc_list":{"value":1900,"currency":"USD","value_usd":1900},"apc_paid":{"value":1900,"currency":"USD","value_usd":1900},"fwci":3.84,"has_fulltext":true,"cited_by_count":191,"citation_normalized_percentile":{"value":0.95744681,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"6","issue":null,"first_page":"16","last_page":"16"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.6991999745368958,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.6991999745368958,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12955","display_name":"Atherosclerosis and Cardiovascular Diseases","score":0.29249998927116394,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11355","display_name":"Inflammatory Biomarkers in Disease Prognosis","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/residual-inflammatory-risk","display_name":"residual inflammatory risk","score":0.9789999723434448},{"id":"https://openalex.org/keywords/atherosclerosis","display_name":"atherosclerosis","score":0.9449999928474426},{"id":"https://openalex.org/keywords/inflammation","display_name":"inflammation","score":0.9580000042915344},{"id":"https://openalex.org/keywords/high-sensitivity-c-reactive-protein","display_name":"high-sensitivity C-reactive protein","score":0.9399999976158142},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.9980000257492065},{"id":"https://openalex.org/keywords/interleukin-1beta","display_name":"IL-1\u03b2","score":0.8360000252723694},{"id":"https://openalex.org/keywords/canakinumab","display_name":"canakinumab","score":0.9440000057220459},{"id":"https://openalex.org/keywords/cantos-trial","display_name":"CANTOS trial","score":0.859000027179718},{"id":"https://openalex.org/keywords/methotrexate","display_name":"methotrexate","score":0.9470000267028809},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.6019999980926514},{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.8069999814033508},{"id":"https://openalex.org/keywords/ldl-cholesterol","display_name":"LDL cholesterol","score":0.6259999871253967},{"id":"https://openalex.org/keywords/innate-immunity","display_name":"innate immunity","score":0.9269999861717224}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5882593393325806},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5534225702285767},{"id":"https://openalex.org/C2909478654","wikidata":"https://www.wikidata.org/wiki/Q844935","display_name":"Atherosclerotic cardiovascular disease","level":3,"score":0.5044940710067749},{"id":"https://openalex.org/C152163801","wikidata":"https://www.wikidata.org/wiki/Q2146057","display_name":"Residual risk","level":2,"score":0.4131860136985779},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.37225112318992615},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3694983720779419},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.31629419326782227}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.3389/fcvm.2019.00016","doi":"https://doi.org/10.3389/fcvm.2019.00016","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fcvm.2019.00016","pdf_url":"https://www.frontiersin.org/articles/10.3389/fcvm.2019.00016/pdf","source":{"id":"https://openalex.org/S2595413687","display_name":"Frontiers in Cardiovascular Medicine","issn_l":"2297-055X","issn":["2297-055X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1","oarl","poland-40","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Cardiovascular Medicine","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5401770","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC6403155","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmid:30873416","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30873416","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in cardiovascular medicine","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6403155","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6403155/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Cardiovasc Med","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:885a524b61ca483c8443a5a47f90438c","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/885a524b61ca483c8443a5a47f90438c","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Cardiovascular Medicine, Vol 6 (2019)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fcvm.2019.00016","doi":"https://doi.org/10.3389/fcvm.2019.00016","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fcvm.2019.00016","pdf_url":"https://www.frontiersin.org/articles/10.3389/fcvm.2019.00016/pdf","source":{"id":"https://openalex.org/S2595413687","display_name":"Frontiers in Cardiovascular Medicine","issn_l":"2297-055X","issn":["2297-055X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1","oarl","poland-40","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Cardiovascular Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1753366813","display_name":"The Vanderbilt Emergency Care Research Training Program","funder_award_id":"K12HL133117","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"},{"id":"https://openalex.org/G5241415837","display_name":null,"funder_award_id":"NIH K12","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G7574202344","display_name":"Training Program in the Epidemiology of CVD","funder_award_id":"T32HL007575","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337338","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2920558304.pdf","grobid_xml":"https://content.openalex.org/works/W2920558304.grobid-xml"},"referenced_works_count":103,"referenced_works":["https://openalex.org/W13023392","https://openalex.org/W146577346","https://openalex.org/W1242386148","https://openalex.org/W1516434930","https://openalex.org/W1520609538","https://openalex.org/W1543609544","https://openalex.org/W1596038729","https://openalex.org/W1812416290","https://openalex.org/W1965135841","https://openalex.org/W1967323415","https://openalex.org/W1967820629","https://openalex.org/W1978049560","https://openalex.org/W1988771872","https://openalex.org/W2008202400","https://openalex.org/W2009800174","https://openalex.org/W2010237936","https://openalex.org/W2012015151","https://openalex.org/W2018135697","https://openalex.org/W2019071303","https://openalex.org/W2027132059","https://openalex.org/W2029615800","https://openalex.org/W2031002085","https://openalex.org/W2031980199","https://openalex.org/W2032049229","https://openalex.org/W2032826669","https://openalex.org/W2035192731","https://openalex.org/W2038636068","https://openalex.org/W2047487535","https://openalex.org/W2047710081","https://openalex.org/W2049350648","https://openalex.org/W2051278307","https://openalex.org/W2058610272","https://openalex.org/W2061631515","https://openalex.org/W2061870298","https://openalex.org/W2062864086","https://openalex.org/W2067504868","https://openalex.org/W2068985697","https://openalex.org/W2070396041","https://openalex.org/W2074115529","https://openalex.org/W2081615427","https://openalex.org/W2082847765","https://openalex.org/W2093707453","https://openalex.org/W2096079570","https://openalex.org/W2102177965","https://openalex.org/W2102785524","https://openalex.org/W2102899779","https://openalex.org/W2108373994","https://openalex.org/W2111099202","https://openalex.org/W2111450463","https://openalex.org/W2113978145","https://openalex.org/W2114278094","https://openalex.org/W2118154631","https://openalex.org/W2119475547","https://openalex.org/W2124376174","https://openalex.org/W2126384096","https://openalex.org/W2126556811","https://openalex.org/W2127469535","https://openalex.org/W2128383347","https://openalex.org/W2134390470","https://openalex.org/W2137983259","https://openalex.org/W2139957955","https://openalex.org/W2141618138","https://openalex.org/W2143727405","https://openalex.org/W2144896295","https://openalex.org/W2149960660","https://openalex.org/W2151672809","https://openalex.org/W2151729372","https://openalex.org/W2151897326","https://openalex.org/W2155123856","https://openalex.org/W2155191102","https://openalex.org/W2155291282","https://openalex.org/W2158540135","https://openalex.org/W2159449551","https://openalex.org/W2163684054","https://openalex.org/W2165241435","https://openalex.org/W2222665820","https://openalex.org/W2274924551","https://openalex.org/W2291369962","https://openalex.org/W2316243284","https://openalex.org/W2316376271","https://openalex.org/W2322095705","https://openalex.org/W2347011549","https://openalex.org/W2399826353","https://openalex.org/W2509676484","https://openalex.org/W2556511870","https://openalex.org/W2588744787","https://openalex.org/W2596179513","https://openalex.org/W2605883714","https://openalex.org/W2748400555","https://openalex.org/W2765749162","https://openalex.org/W2769000982","https://openalex.org/W2791615591","https://openalex.org/W2793103574","https://openalex.org/W2801713528","https://openalex.org/W2884358464","https://openalex.org/W2885197269","https://openalex.org/W2888384778","https://openalex.org/W2899885364","https://openalex.org/W2900446046","https://openalex.org/W3022401702","https://openalex.org/W4236673002","https://openalex.org/W4242263299","https://openalex.org/W6600528653"],"related_works":["https://openalex.org/W4283267264","https://openalex.org/W2900446046","https://openalex.org/W4313237009","https://openalex.org/W2799707816","https://openalex.org/W2804409796","https://openalex.org/W7201953620","https://openalex.org/W3083430288","https://openalex.org/W2918740408","https://openalex.org/W4387844455","https://openalex.org/W7214827378"],"abstract_inverted_index":{"As":[0],"biologic,":[1],"epidemiologic,":[2],"and":[3,25,39,52],"clinical":[4],"trial":[5],"data":[6,110,154],"have":[7,46,69],"demonstrated,":[8],"inflammation":[9,112,140],"is":[10,58],"a":[11,100,116],"key":[12],"driver":[13],"of":[14,18,33,37,55,128,150,176],"atherosclerosis.":[15],"Circulating":[16],"biomarkers":[17],"inflammation,":[19],"including":[20],"high-sensitivity":[21],"C-reactive":[22],"protein":[23],"(hsCRP)":[24],"interleukin-6":[26],"(IL-6),":[27],"are":[28,155],"associated":[29],"with":[30,115,141,157],"increased":[31,76],"risk":[32,42,77],"cardiovascular":[34,64,146,181],"events":[35],"independent":[36,149],"cholesterol":[38,90],"other":[40],"traditional":[41],"factors.":[43],"Randomized":[44],"trials":[45,68],"shown":[47],"that":[48,71,137],"statins":[49],"reduce":[50],"hsCRP,":[51],"the":[53,61,109,126,168],"magnitude":[54],"hsCRP":[56,83],"reduction":[57,62],"proportional":[59],"to":[60,79,113,171,173],"in":[63,82,87,162],"risk.":[65,122],"Additionally,":[66,123],"these":[67],"demonstrated":[70],"many":[72],"individuals":[73],"remain":[74],"at":[75],"due":[78],"persistent":[80],"elevations":[81],"despite":[84],"significant":[85],"reductions":[86],"low-density":[88],"lipoprotein":[89],"(LDL-C)":[91],"levels.":[92],"This":[93],"\"residual":[94],"inflammatory":[95,121],"risk\"":[96],"has":[97],"increasingly":[98],"become":[99],"viable":[101],"pharmacologic":[102],"target.":[103],"In":[104],"this":[105],"review,":[106],"we":[107,124],"summarize":[108],"linking":[111],"atherosclerosis":[114],"particular":[117],"focus":[118],"on":[119],"residual":[120],"detail":[125],"results":[127],"Canakinumab":[129],"Anti-inflammatory":[130],"Thrombosis":[131],"Outcome":[132],"Study":[133],"(CANTOS),":[134],"which":[135,163],"showed":[136],"directly":[138],"reducing":[139],"an":[142],"IL-1\u03b2":[143,170],"antagonist":[144],"reduces":[145],"event":[147,182],"rates":[148],"LDL-C.":[151],"These":[152],"positive":[153],"contrasted":[156],"neutral":[158],"evidence":[159],"from":[160],"CIRT":[161],"low-dose":[164],"methotrexate":[165],"neither":[166],"reduced":[167,180],"critical":[169],"IL-6":[172],"CRP":[174],"pathway":[175],"innate":[177],"immunity,":[178],"nor":[179],"rates.":[183]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2920558304","counts_by_year":[{"year":2026,"cited_by_count":31},{"year":2025,"cited_by_count":21},{"year":2024,"cited_by_count":22},{"year":2023,"cited_by_count":27},{"year":2022,"cited_by_count":29},{"year":2021,"cited_by_count":24},{"year":2020,"cited_by_count":24},{"year":2019,"cited_by_count":13}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2019-03-11T00:00:00"}
